http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017149018-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c68ceb690bac13cb5b5d33beca935a79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44fbe5b02d661b2a28cfb2187a78afce http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ae0d4e4b5a64a9a532bffd8513ed029 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f714b735b7f28dc4374d3ba6e383678 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7968f0e385243743c90075e3c415669d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d55b45d6c45962ebd6d880e2583feda |
| publicationDate | 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017149018-A1 |
| titleOfInvention | Methods and kits for predicting the risk of relapse in patients suffering from idiopathic nephrotic syndrome |
| abstract | The present invention relates to methods and kits for predicting the risk of relapse in patients suffering from idiopathic nephrotic syndrome. No test exists for mechanistically classifying idiopathic and secondary nor for predicting the risk of relapse, with consequent non-specific and toxic treatment regimes. In particular, the present invention relates to a method of predicting the risk of relapse in a patient suffering from idiopathic nephrotic syndrome i) comprising quantifying the level of FoxP3 positive cells and the level of CMIP positive cells in a blood sample obtained from the patient, ii) comparing the level quantified at step i) with their respective predetermined reference values and iii) concluding that the patient is at risk of relapse when the level of FoxP3 positive cells is lower than its predetermined reference value and the level of CMIP positive cells is higher than its predetermined reference value. |
| priorityDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.